US: +1 646-781-8004 | Europe:+44-203-868-8738 | APAC:+91-744-778-0008

Diabetes Care Devices Market

Release date:

Jan-2022

Region:

global

Research Code:MRHC - 10486

Sku:MRHC - 10486

Diabetes Care Devices Market by Type [Diabetes Monitoring (CGM, Test Strips, Self-Monitoring Blood Glucose Meters, Lancets, Haemoglobin A1C Testing Kits)], [Insulin Delivery (Syringes, Pens, Pumps, Jet Injectors)] - Global Forecast to 2028

  • Report ID: MRHC - 10486
  • Pages: 161
  • Jan-2022
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours
COVID-19

This report provides pre & post COVID-19 market estimates.

The Diabetes Care Devices Market is expected to grow at a CAGR of 6.7% from 2021 to reach $31.9 billion by 2028. Increasing prevalence of diabetes, unhealthy lifestyle, product innovations in diabetes care, rising obesity rate, and development of new insulin delivery systems are the key factors driving steady growth of the global diabetes care devices market.

COVID-19 Impact Assessment

The COVID-19 pandemic severely affected the diabetic care device market's growth. COVID-19 infected patients saw their blood glucose levels rise. The stress of infection and the usage of steroids for the COVID-19 treatment contributed to the rise in blood glucose levels, resulting in a higher number of patients. This undoubtedly created opportunities for big players in the market. Due to the rising prevalence of diabetes, many players launched new advanced diabetes care devices and signed collaborations and agreements for diabetes care devices. However, due to lockdowns and travel restrictions, the market experienced a supply chain disruption, resulting in a scarcity of diabetes care devices, but this had only a transitory impact on the diabetic care devices market.

Diabetes Care Devices Market

                                                           Click here to: Get Free Request Sample Copy of this report 

Increasing Prevalence of Diabetes

Diabetes is a chronic condition in which the pancreas does not make enough insulin or efficiently utilizes it to regulate body sugar. Diabetes was the tenth largest cause of mortality in 2019, with an estimated 1.5 million fatalities caused directly by the disease. Type 2 diabetes (also known as non-insulin-dependent diabetes or adult-onset diabetes) is caused by the body's poor utilization of insulin. Type 2 diabetes affects more than 95% of patients with diabetes. Excess body weight and physical inactivity are the main causes of diabetes.

Diabetes is becoming more common worldwide, accounting for 6.7 million deaths in 2021 (Source: International Diabetes Federation). The enormous increase in the diabetes population is mostly due to increased obesity rates worldwide and sedentary lifestyles characterized by poor diets and decreased physical activity. In low- and middle-income nations, prevalence has been increasing faster.

Rising Obesity Rate and Unhealthy and Sedentary Lifestyle

The expanding urbanization and motorization have decreased the degrees of actual work. The WHO indicates that more than 60% of the worldwide populace isn't adequately dynamic. The World Wellbeing Organization expresses that active work is one of the life-supporting elements, and consequently, at whatever stage in life, it secures against any ongoing medical conditions, including many structures of cardiovascular illnesses or diabetes. The danger of type 2 diabetes ascends with expanding body weight at all ages. The pervasiveness of type 2 diabetes is three to multiple times higher in those impacted by corpulence than in ordinary weight and is more probable in those with a weight file (BMI) more prominent than 35 kg/m 2.

Unhealthy way of living that includes smoking and terrible eating routines expands the danger of type-2 diabetes. Shift work, particularly night shift work, has been related to more danger of type-2 diabetes. Smoking is a significant danger factor that brings about higher possibilities of creating diabetes than non-smokers. The danger of diabetes increments with the number of cigarettes smoked each day.

Key Findings in the Global Diabetes Care Devices Market Study:

Diabetes Monitoring Devices Segment is Estimated to Register Fastest Growth in the Diabetes Care Devices Market by 2028

The increased adoption of test strips and self-monitoring blood glucose meters and increasing demand for continuous glucose monitoring with rising awareness of the disease in developing countries are major reasons leading to the growth of the diabetes monitoring devices segment.

Asia-Pacific: Fastest Growing Geographical Market

North America is estimated to command the largest share of the global diabetes care devices market in 2021, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia-Pacific will be the fastest growing market due to, increasing diabetic population, new product launches and distribution strategies undertaken by leading companies, and government initiatives to increase awareness about self-diabetes management.

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past four years . The key players profiled in the global diabetes care devices market report are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), LifeScan IP Holdings, LLC (U.S.), Medtronic PLC (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), and Sanofi AS (France), Tandem Diabetes Care, Inc. (U.S.), Insulate Corporation (U.S.) and DexCom, Inc. (U.S.).

Scope of the Report:

Diabetes Care Devices Market, by Type

  • Diabetes Monitoring Devices
  • Insulin Delivery Devices

Diabetes Care Devices Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key Questions Answered in The Report:

What is the focus of the global diabetes care devices market?

The global diabetes care devices market covers the market size & forecast the various type of devices offered by key players. The diabetes care devices market studied in this report involves the value analysis of segments and subsegments of diabetes care devices at the regional and country levels.

What is the value of revenue generated from the diabetes care devices market across the globe? At what rate is their demand expected to grow for the next 5-7 years?

The global diabetes care devices market is expected to grow at a CAGR of 6.7% from 2021 to 2028 to reach $31.9 billion by 2028.

Which type of diabetes care device is estimated to hold the major share of the market?

Based on the type, the diabetes monitoring devices segment is estimated to hold the major share due to increased adoption of test strips and self-monitoring blood glucose meters and increasing demand for continuous glucose monitoring with rising awareness towards the disease in developing countries.

What are the key factors supporting the growth of this market?

The increasing prevalence of diabetes, rising obesity rate, unhealthy and sedentary lifestyle, product innovations, and development of new insulin delivery systems are the factors supporting the growth of the market.

Who are the major players operating in the global diabetes care devices market?

The key players operating in the global diabetes care devices market are Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), LifeScan IP Holdings, LLC (U.S.), Medtronic PLC (Ireland), Becton, Dickinson, and Company (U.S.), Terumo Corporation (Japan), and Sanofi AS (France), Tandem Diabetes Care, Inc. (U.S.), Insulate Corporation (U.S.) and DexCom, Inc. (U.S.).

Which countries are expected to offer significant growth opportunities for the diabetes care devices market players?

Asia-Pacific is projected to offer significant growth opportunities for the players in this market because of emerging economies like China. Increasing diabetic population, new product launches and distribution strategies undertaken by leading companies, and government initiatives to increase awareness about self-diabetes management are the leading factors for growth in emerging economies.

1.    Introduction 
        1.1.    Market Definition 
        1.2.    Market Ecosystem 
        1.3.    Currency 
        1.4.    Key Stakeholders

2.    Research Methodology 
        2.1.    Research Process 
        2.2.    Data Collection & Validation 
                  2.2.1.    Secondary Research 
                  2.2.2.    Primary Research 
        2.3.    Market Assessment 
                  2.3.1.    Market Size Estimation 
                               2.3.1.1.    Bottom-Up Approach 
                               2.3.1.2.    Top-Down Approach 
                               2.3.1.3.    Growth Forecast 
                  2.3.2.    Market Share Analysis 
        2.4.    Assumptions for the Study 
        2.5.    Limitations for the Study 

3.    Executive Summary 

4.    Market Insights 
        4.1.    Market Overview 
        4.2.    Drivers 
                  4.2.1.    Increasing Prevalence of Diabetes 
                  4.2.2.    Rising Obesity and Prevalence of Disease-Causing Lifestyle 
                  4.2.3.    Product Innovations in Diabetes Care 
                  4.2.4.    Development of Advanced Insulin Delivery Systems 
        4.3.    Restraints 
                  4.3.1.    Insurance Coverage and Reimbursement Scenarios 
                  4.3.2.    Product Recalls 
        4.4.    Opportunities 
                  4.4.1.    Growing Demand for Non-Invasive Glucose Monitoring Devices 
        4.5.    Challenges 
                  4.5.1.    Undiagnosed Diabetes Among Population 
                  4.5.2.    Cost of Diabetes Care Devices 
                  4.5.3.    Limited Accessibility for Diabetes Care Devices in Low- and Middle-Income Countries 
        4.6.    Regulatory Analysis 
                  4.6.1.    North America 
                  4.6.2.    Europe 
                  4.6.3.    Asia-Pacific 
        4.7.    Impact Assessment of Covid-19 Pandemic on Diabetes Care Devices Market 
        4.8.    Diabetes Patients Population Analysis 
                  4.8.1.    Global Diabetes Prevalence 
                  4.8.2.    Diabetes Patient Analysis – U.S. 
                               4.8.2.1.    Number of Patients - Type 1 Vs Type II (U.S.) 
                               4.8.2.2.    Number of Patients Using Monitoring Devices (U.S.) 
                               4.8.2.3.    Number of Patients on Insulin Delivery Devices (U.S.) 
        4.9.    Next-Generation Technologies and Solutions for Diabetes Management 
                  4.9.1.    Smart Insulin Pens 
                  4.9.2.    Closed-Loop Systems 
                  4.9.3.    Next Generation CGM Sensors 

5.    Global Diabetes Care Devices Market, by Type 
        5.1.    Introduction 
        5.2.    Diabetes Monitoring Devices 
                  5.2.1.    Test Strips 
                  5.2.2.    Continuous Blood Glucose Monitoring Devices 
                  5.2.3.    Self-Monitoring Blood Glucose Meters 
                  5.2.4.    Hemoglobin A1c Testing Kits 
                  5.2.5.    Lancets 
        5.3.    Insulin Delivery Devices 
                  5.3.1.    Insulin Pens 
                  5.3.2.    Insulin Syringes 
                  5.3.3.    Insulin Pumps 
                  5.3.4.    Insulin Jet Injectors 

6.    Diabetes Care Devices Market, by Geography 
        6.1.    Introduction 
        6.2.    North America 
                  6.2.1.    U.S. 
                  6.2.2.    Canada

        6.3.    Europe 
                  6.3.1.    Germany 
                  6.3.2.    France 
                  6.3.3.    U.K. 
                  6.3.4.    Italy 
                  6.3.5.    Spain 
                  6.3.6.    Rest of Europe (ROE) 
        6.4.    Asia-Pacific 
                  6.4.1.    Japan 
                  6.4.2.    China 
                  6.4.3.    India 
                  6.4.4.    Rest of Asia-Pacific 
        6.5.    Latin America 
        6.6.    Middle East & Africa 

7.    Competitive Landscape 
        7.1.    Introduction 
        7.2.    Key Growth Strategies 
        7.3.    Competitive Benchmarking 
        7.4.    Market Share Analysis (2020) 
                  7.4.1.    Abbott Laboratories (U.S.) 
                  7.4.2.    Medtronic PLC (Ireland) 
                  7.4.3.    Dexcom, Inc. (U.S.) 
                  7.4.4.    F. Hoffmann-La Roche Ltd (Switzerland) 
        7.5.    Diabetes Care Devices Revenue Analysis (2016-2020) 
                  7.5.1.    Abbott Laboratories 
                  7.5.2.    Medtronic PLC 
                  7.5.3.    DexCom, Inc. 
                  7.5.4.    F. Hoffmann-La Roche Ltd 
                  7.5.5.    LifeScan IP Holdings, LLC 
                  7.5.6.    Becton, Dickinson and Company 
                  7.5.7.    Insulet Corporation 
                  7.5.8.    Novo Nordisk A/S 
                  7.5.9.    Tandem Diabetes Care, Inc. 
                  7.5.10.    Ypsomed AG 

8.    Company Profiles 
        8.1.    Abbott Laboratories 
                  8.1.1.    Business Overview 
                  8.1.2.    Financial Overview 
                  8.1.3.    Product Portfolio 
                  8.1.4.    Strategic Developments 
        8.2.    Ascensia Diabetes Care Holdings AG (A Part of PHC Holdings Corporation) 
                  8.2.1.    Business Overview 
                  8.2.2.    Financial Overview 
                  8.2.3.    Product Portfolio 
                  8.2.4.    Strategic Developments 
        8.3.    Becton, Dickinson and Company 
                  8.3.1.    Business Overview 
                  8.3.2.    Financial Overview 
                  8.3.3.    Product Portfolio 
        8.4.    DexCom, Inc. 
                  8.4.1.    Business Overview 
                  8.4.2.    Financial Overview 
                  8.4.3.    Product Portfolio 
                  8.4.4.    Strategic Developments 
        8.5.    F. Hoffmann-La Roche Ltd. 
                  8.5.1.    Business Overview 
                  8.5.2.    Financialoverview 
                  8.5.3.    Product Portfolio 
                  8.5.4.    Strategic Developments 
        8.6.    Insulet Corporation 
                  8.6.1.    Business Overview 
                  8.6.2.    Financial Overview 
                  8.6.3.    Product Portfolio 
                  8.6.4.    Strategic Developments 
        8.7.    LifeScan IP Holdings, LLC (Subsidiary of Platinum Equity, LLC (U.S.)) 
                  8.7.1.    Business Overview 
                  8.7.2.    Product Portfolio 
                  8.7.3.    Strategic Developments 
        8.8.    Medtronic PLC 
                  8.8.1.    Business Overview 
                  8.8.2.    Financial Overview 
                  8.8.3.    Product Portfolio 
                  8.8.4.    Strategic Developments 
        8.9.    Novo Nordisk A/S 
                  8.9.1.    Business Overview 
                  8.9.2.    Financial Overview 
                  8.9.3.    Product Portfolio 
                  8.9.4.    Strategic Developments 
        8.10.  Sanofi AS 
                  8.10.1.    Business Overview 
                  8.10.2.    Financial Overview 
                  8.10.3.    Product Portfolio 
                  8.10.4.    Strategic Developments 
        8.11.   Tandem Diabetes Care, Inc. 
                  8.11.1.    Business Overview 
                  8.11.2.    Financial Overview 
                  8.11.3.    Product Portfolio 
                  8.11.4.    Strategic Developments 
        8.12.  Terumo Corporation 
                  8.12.1.    Business Overview 
                  8.12.2.    Financial Overview 
                  8.12.3.    Product Portfolio 
                  8.12.4.    Strategic Developments 
        8.13.  Ypsomed AG 
                  8.13.1.    Business Overview 
                  8.13.2.    Financial Overview 
                  8.13.3.    Product Portfolio 
                  8.13.4.    Strategic Developments 

9.    Appendix 
        9.1.    Questionnaire 
        9.2.    Available Customization 

List of Tables

Table 1    Global Diabetes Care Devices Market Drivers: Impact Analysis (2021–2028) 
Table 2    Number of People With Diabetes Among Aged 20-79 Years, 2021 Vs 2030 Vs 2045 (in Million) 
Table 3    Product Innovations by Companies 
Table 4    Non-Invasive Glucose Monitoring Devices Comparison 
Table 5    Some of the Glucose Monitoring Devices Under Development 
Table 6    Examples of Approved Non-Invasive Glucose Monitoring Devices 
Table 7    Proportion and Number of Undiagnosed People (20-79 Years) Living With Diabetes, 2021 
Table 8    Price Estimates for SMBG and CGM (in USD) 
Table 9    Replacement Frequency for Glucose Self-Monitoring Commodities in High Income Countries and Lower Middle Income Countries 
Table 10    Classification of Diabetes Care Devices 
Table 11    Global Prevalence of Diabetes, by Region (2021) 
Table 12    Smart Insulin Pens in the Market 
Table 13    Commercially Available Smart Caps 
Table 14    Current FDA-approved CGM Devices 
Table 15    Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 16    Global Diabetes Monitoring Devices Market Size, by Type, 2019-2028 (USD Million) 
Table 17    Global Diabetes Monitoring Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 18    Global Test Strips Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 19    Global Continuous Blood Glucose Monitoring Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 20    Global Self-Monitoring Blood Glucose Meters Market Size, by Country/Region, 2019–2028 (USD Million)
Table 21    Global Hemoglobin A1c Testing Kits Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 22    Global Lancets Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 23    Global Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 24    Global Insulin Delivery Devices Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 25    Global Insulin Pens Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 26    Global Insulin Syringes Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 27    Global Insulin Pumps Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 28    Global Insulin Jet Injectors Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 29    Global Diabetes Care Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 30    North America: Diabetes Care Devices Market Size, by Country, 2019–2028 (USD Million) 
Table 31    North America: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 32    North America: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 33    North America: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 34    U.S.: Diabetes Indicators 
Table 35    U.S.: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 36    U.S.: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 37    U.S.: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 38    Canada: Diabetes Statistics 
Table 39    Canada: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 40    Canada: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 41    Canada: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 42    Europe: Diabetes Care Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 43    Europe: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 44    Europe: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 45    Europe: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 46    Germany: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 47    Germany: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 48    Germany: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 49    France: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 50    France: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 51    France: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 52    U.K.: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 53    U.K.: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 54    U.K.: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 55    Italy: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 56    Italy: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 57    Italy: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 58    Obesity Prevalence in Spain (2019) 
Table 59    Prevalence of Type 1 Diabetes in Spain (2021) 
Table 60    Spain: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 61    Spain: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 62    Spain: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 63    ROE: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 64    ROE: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 65    ROE: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 66    Asia-Pacific: Diabetes Care Devices Market Size, by Country, 2019–2028 (USD Million) 
Table 67    Asia-Pacific: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 68    Asia-Pacific: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 69    Asia-Pacific: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 70    Japan: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 71    Japan: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 72    Japan: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 73    China: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 74    China: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 75    China: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 76    India: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 77    India: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 78    India: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 79    Diabetes Prevelance in Asian Countries (% Population Ages 20-79) (2010-2019) 
Table 80    ROAPAC: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 81    ROAPAC: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 82    ROAPAC: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 83    Latin America: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 84    Latin America: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 85    Latin America: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 86    Number of Adults (20-79 Years) With Diabetes in Mea Countries (2019 & 2021) 
Table 87    Middle East & Africa: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 88    Middle East & Africa: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 89    Middle East & Africa: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 91    Abbott Laboratories: Diabetes Care Devices Revenue (USD Million) (2017-2020) 
Table 92    Medtronic PLC: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 93    DexCom, Inc.: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 94    F. Hoffmann-La Roche Ltd: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 95    Lifescan IP Holdings LLC.: Diabetes Care Devices Revenue (USD Million) (2016-2018) 
Table 96    Becton, Dickinson and Company: Diabetes Care Devices Revenue (USD Million) (2016-2021) 
Table 97    Insulet Corporation: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 98    Novo Nordisk A/S: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 99    Tandem Diabetes Care, Inc.: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 100    Ypsomed AG: Diabetes Care Devices Revenue (USD Million) (2016-2020) 

List of Figures

Figure 1    Key Stakeholders 
Figure 2    Research Process 
Figure 3    Key Secondary Sources 
Figure 4    Primary Research Techniques 
Figure 5    Key Executives Interviewed 
Figure 6    Breakdown of Primary Interviews (Supply-Side & Demand-Side) 
Figure 7    Market Size Estimation 
Figure 8    Global Diabetes Care Devices Market, by Type, 2021 Vs. 2028 (USD Million) 
Figure 9    Global Diabetes Care Devices Market, by Geography 
Figure 10    Market Dynamics 
Figure 11    Prevalence of Diabetes Across the World (in Million) 
Figure 12    Evolution of Insulin Delivery Systems (2013–2020) 
Figure 13    Diabetes Prevalence (2021 Vs 2030 Vs 2045) 
Figure 14    U.S. Diabetes Patient Analysis 
Figure 15    Diabetes Care Devices Market Size, by Type, 2021 Vs 2028 (USD Million) 
Figure 16    Global Diabetes Care Devices Market Size, by Geography, 2021–2028 (USD Million) 
Figure 17    North America: Diabetes Care Devices Market Snapshot 
Figure 18    Prevalence of Diabetes in the U.S. (2000–2045) 
Figure 19    Prevalence of Diabetes in Europe, by Country (2021) 
Figure 20    Europe: Diabetes Care Devices Market Snapshot 
Figure 21    Prevalence of Diabetes in Germany (2000-2030) 
Figure 22    Prevalence of Diabetes in the U.K. (2000-2045) 
Figure 23    Italy: Share of Population Aged 65 and Above (2010-2020) 
Figure 24    Prevalence of Diabetes in Spain (2011-2045) 
Figure 25    Prevalence Rate of Diabetes in Rest of Europe (2021 Vs 2030) 
Figure 26    Asia-Pacific: Diabetes Care Devices Market Size Snapshot 
Figure 27    Diabetes Prevalence in China (2017-2045) 
Figure 28    Key Growth Strategies Adopted by Leading Players, 2018-2021 
Figure 29    Diabetes Care Devices Market: Competitive Benchmarking 
Figure 30    Diabetes Care Devices Market: Competitive Benchmarking by Geography 
Figure 31    Market Share Analysis: Diabetes Care Devices, 2020 
Figure 32    Abbott Laboratories: Financial Overview (2020) 
Figure 33    PHC Holdings Corporation: Financial Overview (2020) 
Figure 34    Becton, Dickinson and Company: Financial Overview (2021) 
Figure 35    DexCom, Inc.: Financial Overview (2020) 
Figure 36    F. Hoffmann-La Roche Ltd.: Financial Overview (2020) 
Figure 37    Insulet Corporation: Financial Overview (2020) 
Figure 38    Medtronic PLC: Financial Overview (2020) 
Figure 39    Novo Nordisk A/S: Financial Overview (2020) 
Figure 40    Sanofi: Financial Overview (2020) 
Figure 41    Tandem Diabetes Care, Inc.: Financial Overview (2020) 
Figure 42    Terumo Corporation: Financial Overview (2020) 
Figure 43    Ypsomed AG: Financial Overview (2020) 
 

 
Name can only consist of alphabets.
Please provide your full name.
 
Please provide valid email address.
Please provide your email address.
 
Please provide your job title.
 
Please provide your company name.
 
Please provide your company name.
 
Please provide valid phone number.
Please provide your phone number.
 
Please enter minimum 10 characters.
 
Please enter Captcha.
Please enter valid Captcha.

This website is secure and we do not share your personal information with any third party. Privacy Policy

Related Research

The Diabetes Care Devices Market is expected to grow at a CAGR of 6.7% from 2021 to reach $31.9 billion by 2028. Increasing prevalence of diabetes, unhealthy lifestyle, product innovations in diabetes care, rising obesity rate, and development of new insulin delivery systems are the key factors driving steady growth of the global diabetes care devices market.

COVID-19 Impact Assessment

The COVID-19 pandemic severely affected the diabetic care device market's growth. COVID-19 infected patients saw their blood glucose levels rise. The stress of infection and the usage of steroids for the COVID-19 treatment contributed to the rise in blood glucose levels, resulting in a higher number of patients. This undoubtedly created opportunities for big players in the market. Due to the rising prevalence of diabetes, many players launched new advanced diabetes care devices and signed collaborations and agreements for diabetes care devices. However, due to lockdowns and travel restrictions, the market experienced a supply chain disruption, resulting in a scarcity of diabetes care devices, but this had only a transitory impact on the diabetic care devices market.

Diabetes Care Devices Market

                                                           Click here to: Get Free Request Sample Copy of this report 

Increasing Prevalence of Diabetes

Diabetes is a chronic condition in which the pancreas does not make enough insulin or efficiently utilizes it to regulate body sugar. Diabetes was the tenth largest cause of mortality in 2019, with an estimated 1.5 million fatalities caused directly by the disease. Type 2 diabetes (also known as non-insulin-dependent diabetes or adult-onset diabetes) is caused by the body's poor utilization of insulin. Type 2 diabetes affects more than 95% of patients with diabetes. Excess body weight and physical inactivity are the main causes of diabetes.

Diabetes is becoming more common worldwide, accounting for 6.7 million deaths in 2021 (Source: International Diabetes Federation). The enormous increase in the diabetes population is mostly due to increased obesity rates worldwide and sedentary lifestyles characterized by poor diets and decreased physical activity. In low- and middle-income nations, prevalence has been increasing faster.

Rising Obesity Rate and Unhealthy and Sedentary Lifestyle

The expanding urbanization and motorization have decreased the degrees of actual work. The WHO indicates that more than 60% of the worldwide populace isn't adequately dynamic. The World Wellbeing Organization expresses that active work is one of the life-supporting elements, and consequently, at whatever stage in life, it secures against any ongoing medical conditions, including many structures of cardiovascular illnesses or diabetes. The danger of type 2 diabetes ascends with expanding body weight at all ages. The pervasiveness of type 2 diabetes is three to multiple times higher in those impacted by corpulence than in ordinary weight and is more probable in those with a weight file (BMI) more prominent than 35 kg/m 2.

Unhealthy way of living that includes smoking and terrible eating routines expands the danger of type-2 diabetes. Shift work, particularly night shift work, has been related to more danger of type-2 diabetes. Smoking is a significant danger factor that brings about higher possibilities of creating diabetes than non-smokers. The danger of diabetes increments with the number of cigarettes smoked each day.

Key Findings in the Global Diabetes Care Devices Market Study:

Diabetes Monitoring Devices Segment is Estimated to Register Fastest Growth in the Diabetes Care Devices Market by 2028

The increased adoption of test strips and self-monitoring blood glucose meters and increasing demand for continuous glucose monitoring with rising awareness of the disease in developing countries are major reasons leading to the growth of the diabetes monitoring devices segment.

Asia-Pacific: Fastest Growing Geographical Market

North America is estimated to command the largest share of the global diabetes care devices market in 2021, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia-Pacific will be the fastest growing market due to, increasing diabetic population, new product launches and distribution strategies undertaken by leading companies, and government initiatives to increase awareness about self-diabetes management.

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past four years . The key players profiled in the global diabetes care devices market report are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), LifeScan IP Holdings, LLC (U.S.), Medtronic PLC (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), and Sanofi AS (France), Tandem Diabetes Care, Inc. (U.S.), Insulate Corporation (U.S.) and DexCom, Inc. (U.S.).

Scope of the Report:

Diabetes Care Devices Market, by Type

  • Diabetes Monitoring Devices
  • Insulin Delivery Devices

Diabetes Care Devices Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key Questions Answered in The Report:

  Request Sample

1.    Introduction 
        1.1.    Market Definition 
        1.2.    Market Ecosystem 
        1.3.    Currency 
        1.4.    Key Stakeholders

2.    Research Methodology 
        2.1.    Research Process 
        2.2.    Data Collection & Validation 
                  2.2.1.    Secondary Research 
                  2.2.2.    Primary Research 
        2.3.    Market Assessment 
                  2.3.1.    Market Size Estimation 
                               2.3.1.1.    Bottom-Up Approach 
                               2.3.1.2.    Top-Down Approach 
                               2.3.1.3.    Growth Forecast 
                  2.3.2.    Market Share Analysis 
        2.4.    Assumptions for the Study 
        2.5.    Limitations for the Study 

3.    Executive Summary 

4.    Market Insights 
        4.1.    Market Overview 
        4.2.    Drivers 
                  4.2.1.    Increasing Prevalence of Diabetes 
                  4.2.2.    Rising Obesity and Prevalence of Disease-Causing Lifestyle 
                  4.2.3.    Product Innovations in Diabetes Care 
                  4.2.4.    Development of Advanced Insulin Delivery Systems 
        4.3.    Restraints 
                  4.3.1.    Insurance Coverage and Reimbursement Scenarios 
                  4.3.2.    Product Recalls 
        4.4.    Opportunities 
                  4.4.1.    Growing Demand for Non-Invasive Glucose Monitoring Devices 
        4.5.    Challenges 
                  4.5.1.    Undiagnosed Diabetes Among Population 
                  4.5.2.    Cost of Diabetes Care Devices 
                  4.5.3.    Limited Accessibility for Diabetes Care Devices in Low- and Middle-Income Countries 
        4.6.    Regulatory Analysis 
                  4.6.1.    North America 
                  4.6.2.    Europe 
                  4.6.3.    Asia-Pacific 
        4.7.    Impact Assessment of Covid-19 Pandemic on Diabetes Care Devices Market 
        4.8.    Diabetes Patients Population Analysis 
                  4.8.1.    Global Diabetes Prevalence 
                  4.8.2.    Diabetes Patient Analysis – U.S. 
                               4.8.2.1.    Number of Patients - Type 1 Vs Type II (U.S.) 
                               4.8.2.2.    Number of Patients Using Monitoring Devices (U.S.) 
                               4.8.2.3.    Number of Patients on Insulin Delivery Devices (U.S.) 
        4.9.    Next-Generation Technologies and Solutions for Diabetes Management 
                  4.9.1.    Smart Insulin Pens 
                  4.9.2.    Closed-Loop Systems 
                  4.9.3.    Next Generation CGM Sensors 

5.    Global Diabetes Care Devices Market, by Type 
        5.1.    Introduction 
        5.2.    Diabetes Monitoring Devices 
                  5.2.1.    Test Strips 
                  5.2.2.    Continuous Blood Glucose Monitoring Devices 
                  5.2.3.    Self-Monitoring Blood Glucose Meters 
                  5.2.4.    Hemoglobin A1c Testing Kits 
                  5.2.5.    Lancets 
        5.3.    Insulin Delivery Devices 
                  5.3.1.    Insulin Pens 
                  5.3.2.    Insulin Syringes 
                  5.3.3.    Insulin Pumps 
                  5.3.4.    Insulin Jet Injectors 

6.    Diabetes Care Devices Market, by Geography 
        6.1.    Introduction 
        6.2.    North America 
                  6.2.1.    U.S. 
                  6.2.2.    Canada

        6.3.    Europe 
                  6.3.1.    Germany 
                  6.3.2.    France 
                  6.3.3.    U.K. 
                  6.3.4.    Italy 
                  6.3.5.    Spain 
                  6.3.6.    Rest of Europe (ROE) 
        6.4.    Asia-Pacific 
                  6.4.1.    Japan 
                  6.4.2.    China 
                  6.4.3.    India 
                  6.4.4.    Rest of Asia-Pacific 
        6.5.    Latin America 
        6.6.    Middle East & Africa 

7.    Competitive Landscape 
        7.1.    Introduction 
        7.2.    Key Growth Strategies 
        7.3.    Competitive Benchmarking 
        7.4.    Market Share Analysis (2020) 
                  7.4.1.    Abbott Laboratories (U.S.) 
                  7.4.2.    Medtronic PLC (Ireland) 
                  7.4.3.    Dexcom, Inc. (U.S.) 
                  7.4.4.    F. Hoffmann-La Roche Ltd (Switzerland) 
        7.5.    Diabetes Care Devices Revenue Analysis (2016-2020) 
                  7.5.1.    Abbott Laboratories 
                  7.5.2.    Medtronic PLC 
                  7.5.3.    DexCom, Inc. 
                  7.5.4.    F. Hoffmann-La Roche Ltd 
                  7.5.5.    LifeScan IP Holdings, LLC 
                  7.5.6.    Becton, Dickinson and Company 
                  7.5.7.    Insulet Corporation 
                  7.5.8.    Novo Nordisk A/S 
                  7.5.9.    Tandem Diabetes Care, Inc. 
                  7.5.10.    Ypsomed AG 

8.    Company Profiles 
        8.1.    Abbott Laboratories 
                  8.1.1.    Business Overview 
                  8.1.2.    Financial Overview 
                  8.1.3.    Product Portfolio 
                  8.1.4.    Strategic Developments 
        8.2.    Ascensia Diabetes Care Holdings AG (A Part of PHC Holdings Corporation) 
                  8.2.1.    Business Overview 
                  8.2.2.    Financial Overview 
                  8.2.3.    Product Portfolio 
                  8.2.4.    Strategic Developments 
        8.3.    Becton, Dickinson and Company 
                  8.3.1.    Business Overview 
                  8.3.2.    Financial Overview 
                  8.3.3.    Product Portfolio 
        8.4.    DexCom, Inc. 
                  8.4.1.    Business Overview 
                  8.4.2.    Financial Overview 
                  8.4.3.    Product Portfolio 
                  8.4.4.    Strategic Developments 
        8.5.    F. Hoffmann-La Roche Ltd. 
                  8.5.1.    Business Overview 
                  8.5.2.    Financialoverview 
                  8.5.3.    Product Portfolio 
                  8.5.4.    Strategic Developments 
        8.6.    Insulet Corporation 
                  8.6.1.    Business Overview 
                  8.6.2.    Financial Overview 
                  8.6.3.    Product Portfolio 
                  8.6.4.    Strategic Developments 
        8.7.    LifeScan IP Holdings, LLC (Subsidiary of Platinum Equity, LLC (U.S.)) 
                  8.7.1.    Business Overview 
                  8.7.2.    Product Portfolio 
                  8.7.3.    Strategic Developments 
        8.8.    Medtronic PLC 
                  8.8.1.    Business Overview 
                  8.8.2.    Financial Overview 
                  8.8.3.    Product Portfolio 
                  8.8.4.    Strategic Developments 
        8.9.    Novo Nordisk A/S 
                  8.9.1.    Business Overview 
                  8.9.2.    Financial Overview 
                  8.9.3.    Product Portfolio 
                  8.9.4.    Strategic Developments 
        8.10.  Sanofi AS 
                  8.10.1.    Business Overview 
                  8.10.2.    Financial Overview 
                  8.10.3.    Product Portfolio 
                  8.10.4.    Strategic Developments 
        8.11.   Tandem Diabetes Care, Inc. 
                  8.11.1.    Business Overview 
                  8.11.2.    Financial Overview 
                  8.11.3.    Product Portfolio 
                  8.11.4.    Strategic Developments 
        8.12.  Terumo Corporation 
                  8.12.1.    Business Overview 
                  8.12.2.    Financial Overview 
                  8.12.3.    Product Portfolio 
                  8.12.4.    Strategic Developments 
        8.13.  Ypsomed AG 
                  8.13.1.    Business Overview 
                  8.13.2.    Financial Overview 
                  8.13.3.    Product Portfolio 
                  8.13.4.    Strategic Developments 

9.    Appendix 
        9.1.    Questionnaire 
        9.2.    Available Customization 

List of Tables

Table 1    Global Diabetes Care Devices Market Drivers: Impact Analysis (2021–2028) 
Table 2    Number of People With Diabetes Among Aged 20-79 Years, 2021 Vs 2030 Vs 2045 (in Million) 
Table 3    Product Innovations by Companies 
Table 4    Non-Invasive Glucose Monitoring Devices Comparison 
Table 5    Some of the Glucose Monitoring Devices Under Development 
Table 6    Examples of Approved Non-Invasive Glucose Monitoring Devices 
Table 7    Proportion and Number of Undiagnosed People (20-79 Years) Living With Diabetes, 2021 
Table 8    Price Estimates for SMBG and CGM (in USD) 
Table 9    Replacement Frequency for Glucose Self-Monitoring Commodities in High Income Countries and Lower Middle Income Countries 
Table 10    Classification of Diabetes Care Devices 
Table 11    Global Prevalence of Diabetes, by Region (2021) 
Table 12    Smart Insulin Pens in the Market 
Table 13    Commercially Available Smart Caps 
Table 14    Current FDA-approved CGM Devices 
Table 15    Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 16    Global Diabetes Monitoring Devices Market Size, by Type, 2019-2028 (USD Million) 
Table 17    Global Diabetes Monitoring Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 18    Global Test Strips Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 19    Global Continuous Blood Glucose Monitoring Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 20    Global Self-Monitoring Blood Glucose Meters Market Size, by Country/Region, 2019–2028 (USD Million)
Table 21    Global Hemoglobin A1c Testing Kits Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 22    Global Lancets Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 23    Global Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 24    Global Insulin Delivery Devices Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 25    Global Insulin Pens Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 26    Global Insulin Syringes Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 27    Global Insulin Pumps Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 28    Global Insulin Jet Injectors Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 29    Global Diabetes Care Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 30    North America: Diabetes Care Devices Market Size, by Country, 2019–2028 (USD Million) 
Table 31    North America: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 32    North America: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 33    North America: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 34    U.S.: Diabetes Indicators 
Table 35    U.S.: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 36    U.S.: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 37    U.S.: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 38    Canada: Diabetes Statistics 
Table 39    Canada: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 40    Canada: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 41    Canada: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 42    Europe: Diabetes Care Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 43    Europe: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 44    Europe: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 45    Europe: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 46    Germany: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 47    Germany: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 48    Germany: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 49    France: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 50    France: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 51    France: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 52    U.K.: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 53    U.K.: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 54    U.K.: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 55    Italy: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 56    Italy: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 57    Italy: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 58    Obesity Prevalence in Spain (2019) 
Table 59    Prevalence of Type 1 Diabetes in Spain (2021) 
Table 60    Spain: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 61    Spain: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 62    Spain: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 63    ROE: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 64    ROE: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 65    ROE: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 66    Asia-Pacific: Diabetes Care Devices Market Size, by Country, 2019–2028 (USD Million) 
Table 67    Asia-Pacific: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 68    Asia-Pacific: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 69    Asia-Pacific: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 70    Japan: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 71    Japan: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 72    Japan: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 73    China: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 74    China: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 75    China: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 76    India: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 77    India: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 78    India: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 79    Diabetes Prevelance in Asian Countries (% Population Ages 20-79) (2010-2019) 
Table 80    ROAPAC: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 81    ROAPAC: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 82    ROAPAC: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 83    Latin America: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 84    Latin America: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 85    Latin America: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 86    Number of Adults (20-79 Years) With Diabetes in Mea Countries (2019 & 2021) 
Table 87    Middle East & Africa: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 88    Middle East & Africa: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 89    Middle East & Africa: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 91    Abbott Laboratories: Diabetes Care Devices Revenue (USD Million) (2017-2020) 
Table 92    Medtronic PLC: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 93    DexCom, Inc.: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 94    F. Hoffmann-La Roche Ltd: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 95    Lifescan IP Holdings LLC.: Diabetes Care Devices Revenue (USD Million) (2016-2018) 
Table 96    Becton, Dickinson and Company: Diabetes Care Devices Revenue (USD Million) (2016-2021) 
Table 97    Insulet Corporation: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 98    Novo Nordisk A/S: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 99    Tandem Diabetes Care, Inc.: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 100    Ypsomed AG: Diabetes Care Devices Revenue (USD Million) (2016-2020) 

List of Figures

Figure 1    Key Stakeholders 
Figure 2    Research Process 
Figure 3    Key Secondary Sources 
Figure 4    Primary Research Techniques 
Figure 5    Key Executives Interviewed 
Figure 6    Breakdown of Primary Interviews (Supply-Side & Demand-Side) 
Figure 7    Market Size Estimation 
Figure 8    Global Diabetes Care Devices Market, by Type, 2021 Vs. 2028 (USD Million) 
Figure 9    Global Diabetes Care Devices Market, by Geography 
Figure 10    Market Dynamics 
Figure 11    Prevalence of Diabetes Across the World (in Million) 
Figure 12    Evolution of Insulin Delivery Systems (2013–2020) 
Figure 13    Diabetes Prevalence (2021 Vs 2030 Vs 2045) 
Figure 14    U.S. Diabetes Patient Analysis 
Figure 15    Diabetes Care Devices Market Size, by Type, 2021 Vs 2028 (USD Million) 
Figure 16    Global Diabetes Care Devices Market Size, by Geography, 2021–2028 (USD Million) 
Figure 17    North America: Diabetes Care Devices Market Snapshot 
Figure 18    Prevalence of Diabetes in the U.S. (2000–2045) 
Figure 19    Prevalence of Diabetes in Europe, by Country (2021) 
Figure 20    Europe: Diabetes Care Devices Market Snapshot 
Figure 21    Prevalence of Diabetes in Germany (2000-2030) 
Figure 22    Prevalence of Diabetes in the U.K. (2000-2045) 
Figure 23    Italy: Share of Population Aged 65 and Above (2010-2020) 
Figure 24    Prevalence of Diabetes in Spain (2011-2045) 
Figure 25    Prevalence Rate of Diabetes in Rest of Europe (2021 Vs 2030) 
Figure 26    Asia-Pacific: Diabetes Care Devices Market Size Snapshot 
Figure 27    Diabetes Prevalence in China (2017-2045) 
Figure 28    Key Growth Strategies Adopted by Leading Players, 2018-2021 
Figure 29    Diabetes Care Devices Market: Competitive Benchmarking 
Figure 30    Diabetes Care Devices Market: Competitive Benchmarking by Geography 
Figure 31    Market Share Analysis: Diabetes Care Devices, 2020 
Figure 32    Abbott Laboratories: Financial Overview (2020) 
Figure 33    PHC Holdings Corporation: Financial Overview (2020) 
Figure 34    Becton, Dickinson and Company: Financial Overview (2021) 
Figure 35    DexCom, Inc.: Financial Overview (2020) 
Figure 36    F. Hoffmann-La Roche Ltd.: Financial Overview (2020) 
Figure 37    Insulet Corporation: Financial Overview (2020) 
Figure 38    Medtronic PLC: Financial Overview (2020) 
Figure 39    Novo Nordisk A/S: Financial Overview (2020) 
Figure 40    Sanofi: Financial Overview (2020) 
Figure 41    Tandem Diabetes Care, Inc.: Financial Overview (2020) 
Figure 42    Terumo Corporation: Financial Overview (2020) 
Figure 43    Ypsomed AG: Financial Overview (2020) 
 

  Request Sample

1.    Introduction 
        1.1.    Market Definition 
        1.2.    Market Ecosystem 
        1.3.    Currency 
        1.4.    Key Stakeholders

2.    Research Methodology 
        2.1.    Research Process 
        2.2.    Data Collection & Validation 
                  2.2.1.    Secondary Research 
                  2.2.2.    Primary Research 
        2.3.    Market Assessment 
                  2.3.1.    Market Size Estimation 
                               2.3.1.1.    Bottom-Up Approach 
                               2.3.1.2.    Top-Down Approach 
                               2.3.1.3.    Growth Forecast 
                  2.3.2.    Market Share Analysis 
        2.4.    Assumptions for the Study 
        2.5.    Limitations for the Study 

3.    Executive Summary 

4.    Market Insights 
        4.1.    Market Overview 
        4.2.    Drivers 
                  4.2.1.    Increasing Prevalence of Diabetes 
                  4.2.2.    Rising Obesity and Prevalence of Disease-Causing Lifestyle 
                  4.2.3.    Product Innovations in Diabetes Care 
                  4.2.4.    Development of Advanced Insulin Delivery Systems 
        4.3.    Restraints 
                  4.3.1.    Insurance Coverage and Reimbursement Scenarios 
                  4.3.2.    Product Recalls 
        4.4.    Opportunities 
                  4.4.1.    Growing Demand for Non-Invasive Glucose Monitoring Devices 
        4.5.    Challenges 
                  4.5.1.    Undiagnosed Diabetes Among Population 
                  4.5.2.    Cost of Diabetes Care Devices 
                  4.5.3.    Limited Accessibility for Diabetes Care Devices in Low- and Middle-Income Countries 
        4.6.    Regulatory Analysis 
                  4.6.1.    North America 
                  4.6.2.    Europe 
                  4.6.3.    Asia-Pacific 
        4.7.    Impact Assessment of Covid-19 Pandemic on Diabetes Care Devices Market 
        4.8.    Diabetes Patients Population Analysis 
                  4.8.1.    Global Diabetes Prevalence 
                  4.8.2.    Diabetes Patient Analysis – U.S. 
                               4.8.2.1.    Number of Patients - Type 1 Vs Type II (U.S.) 
                               4.8.2.2.    Number of Patients Using Monitoring Devices (U.S.) 
                               4.8.2.3.    Number of Patients on Insulin Delivery Devices (U.S.) 
        4.9.    Next-Generation Technologies and Solutions for Diabetes Management 
                  4.9.1.    Smart Insulin Pens 
                  4.9.2.    Closed-Loop Systems 
                  4.9.3.    Next Generation CGM Sensors 

5.    Global Diabetes Care Devices Market, by Type 
        5.1.    Introduction 
        5.2.    Diabetes Monitoring Devices 
                  5.2.1.    Test Strips 
                  5.2.2.    Continuous Blood Glucose Monitoring Devices 
                  5.2.3.    Self-Monitoring Blood Glucose Meters 
                  5.2.4.    Hemoglobin A1c Testing Kits 
                  5.2.5.    Lancets 
        5.3.    Insulin Delivery Devices 
                  5.3.1.    Insulin Pens 
                  5.3.2.    Insulin Syringes 
                  5.3.3.    Insulin Pumps 
                  5.3.4.    Insulin Jet Injectors 

6.    Diabetes Care Devices Market, by Geography 
        6.1.    Introduction 
        6.2.    North America 
                  6.2.1.    U.S. 
                  6.2.2.    Canada

        6.3.    Europe 
                  6.3.1.    Germany 
                  6.3.2.    France 
                  6.3.3.    U.K. 
                  6.3.4.    Italy 
                  6.3.5.    Spain 
                  6.3.6.    Rest of Europe (ROE) 
        6.4.    Asia-Pacific 
                  6.4.1.    Japan 
                  6.4.2.    China 
                  6.4.3.    India 
                  6.4.4.    Rest of Asia-Pacific 
        6.5.    Latin America 
        6.6.    Middle East & Africa 

7.    Competitive Landscape 
        7.1.    Introduction 
        7.2.    Key Growth Strategies 
        7.3.    Competitive Benchmarking 
        7.4.    Market Share Analysis (2020) 
                  7.4.1.    Abbott Laboratories (U.S.) 
                  7.4.2.    Medtronic PLC (Ireland) 
                  7.4.3.    Dexcom, Inc. (U.S.) 
                  7.4.4.    F. Hoffmann-La Roche Ltd (Switzerland) 
        7.5.    Diabetes Care Devices Revenue Analysis (2016-2020) 
                  7.5.1.    Abbott Laboratories 
                  7.5.2.    Medtronic PLC 
                  7.5.3.    DexCom, Inc. 
                  7.5.4.    F. Hoffmann-La Roche Ltd 
                  7.5.5.    LifeScan IP Holdings, LLC 
                  7.5.6.    Becton, Dickinson and Company 
                  7.5.7.    Insulet Corporation 
                  7.5.8.    Novo Nordisk A/S 
                  7.5.9.    Tandem Diabetes Care, Inc. 
                  7.5.10.    Ypsomed AG 

8.    Company Profiles 
        8.1.    Abbott Laboratories 
                  8.1.1.    Business Overview 
                  8.1.2.    Financial Overview 
                  8.1.3.    Product Portfolio 
                  8.1.4.    Strategic Developments 
        8.2.    Ascensia Diabetes Care Holdings AG (A Part of PHC Holdings Corporation) 
                  8.2.1.    Business Overview 
                  8.2.2.    Financial Overview 
                  8.2.3.    Product Portfolio 
                  8.2.4.    Strategic Developments 
        8.3.    Becton, Dickinson and Company 
                  8.3.1.    Business Overview 
                  8.3.2.    Financial Overview 
                  8.3.3.    Product Portfolio 
        8.4.    DexCom, Inc. 
                  8.4.1.    Business Overview 
                  8.4.2.    Financial Overview 
                  8.4.3.    Product Portfolio 
                  8.4.4.    Strategic Developments 
        8.5.    F. Hoffmann-La Roche Ltd. 
                  8.5.1.    Business Overview 
                  8.5.2.    Financialoverview 
                  8.5.3.    Product Portfolio 
                  8.5.4.    Strategic Developments 
        8.6.    Insulet Corporation 
                  8.6.1.    Business Overview 
                  8.6.2.    Financial Overview 
                  8.6.3.    Product Portfolio 
                  8.6.4.    Strategic Developments 
        8.7.    LifeScan IP Holdings, LLC (Subsidiary of Platinum Equity, LLC (U.S.)) 
                  8.7.1.    Business Overview 
                  8.7.2.    Product Portfolio 
                  8.7.3.    Strategic Developments 
        8.8.    Medtronic PLC 
                  8.8.1.    Business Overview 
                  8.8.2.    Financial Overview 
                  8.8.3.    Product Portfolio 
                  8.8.4.    Strategic Developments 
        8.9.    Novo Nordisk A/S 
                  8.9.1.    Business Overview 
                  8.9.2.    Financial Overview 
                  8.9.3.    Product Portfolio 
                  8.9.4.    Strategic Developments 
        8.10.  Sanofi AS 
                  8.10.1.    Business Overview 
                  8.10.2.    Financial Overview 
                  8.10.3.    Product Portfolio 
                  8.10.4.    Strategic Developments 
        8.11.   Tandem Diabetes Care, Inc. 
                  8.11.1.    Business Overview 
                  8.11.2.    Financial Overview 
                  8.11.3.    Product Portfolio 
                  8.11.4.    Strategic Developments 
        8.12.  Terumo Corporation 
                  8.12.1.    Business Overview 
                  8.12.2.    Financial Overview 
                  8.12.3.    Product Portfolio 
                  8.12.4.    Strategic Developments 
        8.13.  Ypsomed AG 
                  8.13.1.    Business Overview 
                  8.13.2.    Financial Overview 
                  8.13.3.    Product Portfolio 
                  8.13.4.    Strategic Developments 

9.    Appendix 
        9.1.    Questionnaire 
        9.2.    Available Customization 

List of Tables

Table 1    Global Diabetes Care Devices Market Drivers: Impact Analysis (2021–2028) 
Table 2    Number of People With Diabetes Among Aged 20-79 Years, 2021 Vs 2030 Vs 2045 (in Million) 
Table 3    Product Innovations by Companies 
Table 4    Non-Invasive Glucose Monitoring Devices Comparison 
Table 5    Some of the Glucose Monitoring Devices Under Development 
Table 6    Examples of Approved Non-Invasive Glucose Monitoring Devices 
Table 7    Proportion and Number of Undiagnosed People (20-79 Years) Living With Diabetes, 2021 
Table 8    Price Estimates for SMBG and CGM (in USD) 
Table 9    Replacement Frequency for Glucose Self-Monitoring Commodities in High Income Countries and Lower Middle Income Countries 
Table 10    Classification of Diabetes Care Devices 
Table 11    Global Prevalence of Diabetes, by Region (2021) 
Table 12    Smart Insulin Pens in the Market 
Table 13    Commercially Available Smart Caps 
Table 14    Current FDA-approved CGM Devices 
Table 15    Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 16    Global Diabetes Monitoring Devices Market Size, by Type, 2019-2028 (USD Million) 
Table 17    Global Diabetes Monitoring Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 18    Global Test Strips Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 19    Global Continuous Blood Glucose Monitoring Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 20    Global Self-Monitoring Blood Glucose Meters Market Size, by Country/Region, 2019–2028 (USD Million)
Table 21    Global Hemoglobin A1c Testing Kits Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 22    Global Lancets Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 23    Global Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 24    Global Insulin Delivery Devices Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 25    Global Insulin Pens Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 26    Global Insulin Syringes Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 27    Global Insulin Pumps Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 28    Global Insulin Jet Injectors Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 29    Global Diabetes Care Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 30    North America: Diabetes Care Devices Market Size, by Country, 2019–2028 (USD Million) 
Table 31    North America: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 32    North America: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 33    North America: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 34    U.S.: Diabetes Indicators 
Table 35    U.S.: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 36    U.S.: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 37    U.S.: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 38    Canada: Diabetes Statistics 
Table 39    Canada: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 40    Canada: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 41    Canada: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 42    Europe: Diabetes Care Devices Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 43    Europe: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 44    Europe: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 45    Europe: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 46    Germany: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 47    Germany: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 48    Germany: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 49    France: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 50    France: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 51    France: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 52    U.K.: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 53    U.K.: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 54    U.K.: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 55    Italy: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 56    Italy: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 57    Italy: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 58    Obesity Prevalence in Spain (2019) 
Table 59    Prevalence of Type 1 Diabetes in Spain (2021) 
Table 60    Spain: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 61    Spain: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 62    Spain: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 63    ROE: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 64    ROE: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 65    ROE: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 66    Asia-Pacific: Diabetes Care Devices Market Size, by Country, 2019–2028 (USD Million) 
Table 67    Asia-Pacific: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 68    Asia-Pacific: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 69    Asia-Pacific: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 70    Japan: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 71    Japan: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 72    Japan: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 73    China: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 74    China: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 75    China: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 76    India: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 77    India: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 78    India: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 79    Diabetes Prevelance in Asian Countries (% Population Ages 20-79) (2010-2019) 
Table 80    ROAPAC: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 81    ROAPAC: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 82    ROAPAC: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 83    Latin America: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 84    Latin America: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 85    Latin America: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 86    Number of Adults (20-79 Years) With Diabetes in Mea Countries (2019 & 2021) 
Table 87    Middle East & Africa: Diabetes Care Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 88    Middle East & Africa: Diabetes Monitoring Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 89    Middle East & Africa: Insulin Delivery Devices Market Size, by Type, 2019–2028 (USD Million) 
Table 91    Abbott Laboratories: Diabetes Care Devices Revenue (USD Million) (2017-2020) 
Table 92    Medtronic PLC: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 93    DexCom, Inc.: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 94    F. Hoffmann-La Roche Ltd: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 95    Lifescan IP Holdings LLC.: Diabetes Care Devices Revenue (USD Million) (2016-2018) 
Table 96    Becton, Dickinson and Company: Diabetes Care Devices Revenue (USD Million) (2016-2021) 
Table 97    Insulet Corporation: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 98    Novo Nordisk A/S: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 99    Tandem Diabetes Care, Inc.: Diabetes Care Devices Revenue (USD Million) (2016-2020) 
Table 100    Ypsomed AG: Diabetes Care Devices Revenue (USD Million) (2016-2020) 

List of Figures

Figure 1    Key Stakeholders 
Figure 2    Research Process 
Figure 3    Key Secondary Sources 
Figure 4    Primary Research Techniques 
Figure 5    Key Executives Interviewed 
Figure 6    Breakdown of Primary Interviews (Supply-Side & Demand-Side) 
Figure 7    Market Size Estimation 
Figure 8    Global Diabetes Care Devices Market, by Type, 2021 Vs. 2028 (USD Million) 
Figure 9    Global Diabetes Care Devices Market, by Geography 
Figure 10    Market Dynamics 
Figure 11    Prevalence of Diabetes Across the World (in Million) 
Figure 12    Evolution of Insulin Delivery Systems (2013–2020) 
Figure 13    Diabetes Prevalence (2021 Vs 2030 Vs 2045) 
Figure 14    U.S. Diabetes Patient Analysis 
Figure 15    Diabetes Care Devices Market Size, by Type, 2021 Vs 2028 (USD Million) 
Figure 16    Global Diabetes Care Devices Market Size, by Geography, 2021–2028 (USD Million) 
Figure 17    North America: Diabetes Care Devices Market Snapshot 
Figure 18    Prevalence of Diabetes in the U.S. (2000–2045) 
Figure 19    Prevalence of Diabetes in Europe, by Country (2021) 
Figure 20    Europe: Diabetes Care Devices Market Snapshot 
Figure 21    Prevalence of Diabetes in Germany (2000-2030) 
Figure 22    Prevalence of Diabetes in the U.K. (2000-2045) 
Figure 23    Italy: Share of Population Aged 65 and Above (2010-2020) 
Figure 24    Prevalence of Diabetes in Spain (2011-2045) 
Figure 25    Prevalence Rate of Diabetes in Rest of Europe (2021 Vs 2030) 
Figure 26    Asia-Pacific: Diabetes Care Devices Market Size Snapshot 
Figure 27    Diabetes Prevalence in China (2017-2045) 
Figure 28    Key Growth Strategies Adopted by Leading Players, 2018-2021 
Figure 29    Diabetes Care Devices Market: Competitive Benchmarking 
Figure 30    Diabetes Care Devices Market: Competitive Benchmarking by Geography 
Figure 31    Market Share Analysis: Diabetes Care Devices, 2020 
Figure 32    Abbott Laboratories: Financial Overview (2020) 
Figure 33    PHC Holdings Corporation: Financial Overview (2020) 
Figure 34    Becton, Dickinson and Company: Financial Overview (2021) 
Figure 35    DexCom, Inc.: Financial Overview (2020) 
Figure 36    F. Hoffmann-La Roche Ltd.: Financial Overview (2020) 
Figure 37    Insulet Corporation: Financial Overview (2020) 
Figure 38    Medtronic PLC: Financial Overview (2020) 
Figure 39    Novo Nordisk A/S: Financial Overview (2020) 
Figure 40    Sanofi: Financial Overview (2020) 
Figure 41    Tandem Diabetes Care, Inc.: Financial Overview (2020) 
Figure 42    Terumo Corporation: Financial Overview (2020) 
Figure 43    Ypsomed AG: Financial Overview (2020) 
 

  Request Sample
Related Research
-->